
"Nebraska Medicine Introduces Innovative AFib Heart Procedure"
Nebraska Medicine has introduced a new heart procedure called pulsed-field ablation to treat atrial fibrillation (AFib), a condition where the heart beats irregularly. This procedure, approved by the FDA in December 2023, uses a hydrating electrical field to denature the tissue and make it electrically inactive, without the risks associated with thermal energy. Dr. Jason Payne, a cardiologist at Nebraska Medicine, highlights the safety and efficiency of this procedure, which allows patients to be discharged within a few hours and experience a quick return to normalcy. With the rising number of Nebraskans being diagnosed with AFib, the hospital aims to meet the demand for this procedure in a faster and safer manner.


